Skip to Content

EPIRUS Biopharmaceuticals Inc EPRSQ

Morningstar Rating
$0.00 0.00 (0.00%)
View Full Chart
Unlock Our Analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

EPRSQ is trading at a 58% discount.
Price
$0.00
Fair Value
$9.92
Uncertainty
Extreme
1-Star Price
$8.50
5-Star Price
Economic Moat
Vnw
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if EPRSQ is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.00
Day Range
$0.000.00
52-Week Range
$0.000.00
Bid/Ask
$0.00 / $0.01
Market Cap
$26.18
Volume/Avg
191 / 11,461

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield
Dividend Yield (Forward)
Total Yield

Company Profile

EPIRUS Biopharmaceuticals Inc is a global biopharmaceutical company focused on building biosimilar business targeting rare diseases by improving patient access through cost-effective medicines. The product candidates of the company are BOW080 for the potential treatment of ultra-rare blood disorders and BOW070 for the potential treatment of an uncommon lymphoproliferative disorder known as Castleman’s disease. The group generally operates through the United States.
Sector
Healthcare
Industry
Biotechnology
Stock Style Box
Small Growth
Total Number of Employees
73

Valuation

Metric
EPRSQ
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
EPRSQ
Quick Ratio
0.64
Current Ratio
0.79
Interest Coverage
−42.19
Quick Ratio
EPRSQ

Profitability

Metric
EPRSQ
Return on Assets (Normalized)
−71.15%
Return on Equity (Normalized)
−115.61%
Return on Invested Capital (Normalized)
−88.71%
Return on Assets
EPRSQ

Biotechnology Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
NVO
Novo Nordisk A/S ADRNbq$458.6 Bil
VRTX
Vertex Pharmaceuticals IncBtkqbl$90.5 Bil
REGN
Regeneron Pharmaceuticals IncFmrcwm$88.8 Bil
SGEN
Seagen Inc Ordinary SharesGtgtnj$40.1 Bil
MRNA
Moderna IncVtbq$30.4 Bil
ARGX
argenx SE ADRMhzm$27.0 Bil
BNTX
BioNTech SE ADRMky$23.6 Bil
ALNY
Alnylam Pharmaceuticals IncTkywmz$21.5 Bil
BMRN
Biomarin Pharmaceutical IncKmtpt$17.4 Bil
INCY
Incyte CorpCjhwtw$12.1 Bil